Professional Documents
Culture Documents
SUBMITTED TO
Ms. Nusrat Khan Lecture Department of Finance University of Dhaka
SUBMITTED BY
Section A BBA 16th Batch Department of Finance University of Dhaka
ABOUT US
SL NO. 1 2 3 4 5 6 7 8 9
NAME Md. Rabin Islam Mohammad Junaid Shawon Md. Zahidul Islam Md. Rashed Karim Rashid Muntasir Md. Zahirul Islam Khan Md. Sanowar Hossain Ariful Hossain Md. Mahbubur Rahman Khan
LETTER OF TRANSMITTAL
November 2, 2011 Ms. Nusrat Khan Lecturer Department of Finance University of Dhaka Dear Madam, It is our satisfaction to submit this report, which you assigned us. The topic of our report is Applications of Statistics On Banking and Pharmaceutical Companies as a part of the requirements under the Course of Business Statistics II. Working on this report was a great opportunity for us to acquire knowledge about many applications of descriptive & inferential statistics. We are thankful to you, as you allowed us to perform the study and to submit the report. We hope that the report will meet the standard and will serve its purpose.
Sincerely Yours,
ACKNOWLEDGEMENT
For the completion of this study we cant deserve all praise. There were a lot of people who helped us by providing valuable information, advice and guidance for the completion of this Report in the scheduled time. Course Report is an essential part of BBA program as one can gather practical knowledge within the short period of time by observing and doing the works of chosen organizations. In this regard our Report has been arranged. At first we like to pay our heartiest thanks to ALMIGHTY, for helping us to do all the works with perfection. Having prepared this report, we would like to give our thanks to the Department of Finance and all the faculties of the department as they have given us the opportunity to be a part of the BBA Program. We also thank them for preparing such a curriculum as a part of which we have been able to accomplish this report. We would like to pay our gratitude to our supervising Course teacher Ms. Nusrat Khan who instructed us in the right way and gave us proper guidelines for preparing this Report.
E X E C U T I V E S U M MA R Y
We have prepared this report on the study of Applications of Statistics On Banking and Pharmaceutical Companies in which we have discussed the applications of some statistical tools in business and commerce. These tools are Time series & Forecasting Multiple regression & correlation analysis
The report starts with introducing the origin, objectives & methodology of the report at the first part. The origin section describes the background of the preparation of this report, while the objectives section explains the objectives of the preparation of this report. The methodology section deals with the means of preparation of this report and the processes that we have followed. Then the report describes various important topics of time series analysis & multiple regression & correlation analysis in the theoretical knowledge at the second part. Thereafter at the third part there are Company profiles of four selected companies from two different industries. Then we have shown the application of some statistical tools on these companies.
I N T R O DU C T I O N
Origin of the Report:
This Report is generated under the academic supervision of Ms. Nusrat Khan, Lecturer, Department of Finance, University of Dhaka. The report is a prerequisite for the completion of the course Business Statistics II under BBA Program. Each student has to work on a report within a predetermined group over the period of this Program. The assigned topic for our Report is Applications of Statistics On Banking and
Pharmaceutical Companies
THEORETICAL KNOWLEDGE
Time Series & Forecasting:
A time series is a collection of data recorded over a period of time; weekly, monthly, quarterly or yearly. Time series can be used by management to make current decisions & plans based on long-term forecasting.
Components of a Time-series:
Secular trend: The smooth long-term direction of a time series. Cyclical variation: The rise & fall of a time series over periods longer than one year. Seasonal variation: Patterns of change in a time series within a year. Irregular variation: Episodic & residual fluctuations.
Linear Trend:
The long-term trend of many business series, such as sales, exports & production often approximates a straight line. The equation to describe this growth is: = a+ bt Where: is the projected value of the y variable for a selected value of t. a is the Y-intercept. It is the estimated value of y when t = 0. b is the slope of the line or the average change in for each increase of one unit in t. t is any value of time that is selected.
Growth Rate: It indicates that during the period of 200X to 200Y dependent variable
increases or decreases at an average of growth rate per year.
Acceleration Rate: It indicates that in the years to come growth rate will be increased
or decreased at an average rate of acceleration rate per year of the previous years growth rate.
Multiple Regression & Correlation Analysis: Multiple Regressions: The general descriptive form of a multiple regression equation
is
y = a + b1X1+ b2X2++b3X3+. + bkXk
where a is the Y-intercept when all Xs are zero, b refers to the sample regression coefficient & X refers to the value of the various independent variables.
Global Test: A global test is used to investigate whether any of the independent
variables have significant regression coefficients. The test statistics is the F distribution.
COMPANY PROFILE
Established as the first private sector bank fully owned by Bangladeshi entrepreneurs, NBL has been flourishing as the largest private sector Bank with the passage of time after facing many stress and strain. To keep pace with time and in harmony with national and international economic activities and for rendering all modern services, NBL, as a financial institution, automated all its branches with computer networks in accordance with the competitive commercial demand of time. Moreover, considering its forthcoming future, the infrastructure of the Bank has been rearranging. The expectation of all class businessmen, entrepreneurs and general public is much more to NBL. At present we have 145 branches under our branch network National Bank Limited was born as the first hundred percent Bangladeshi owned Bank in the private sector. From the very inception, it was the firm determination of National Bank Limited to play a vital role in the national economy. We are determined to bring back the long forgotten taste of banking services and flavors. We want to serve each one promptly and with a sense of dedication and dignity.
At present, NBL has been carrying on business through its 130 branches and 15 SME / Agri Branches (total 145 service locations) spread all over the country. Since the very beginning, the bank has exerted much emphasis on overseas operations and handled a sizable quantum of home bound foreign remittance. It has drawing arrangements with 415 correspondents in 75 countries of the world, as well as with 37 overseas Exchange Companies located in 13 countries. NBL was the first domestic bank to establish agency arrangements with the world famous Western Union in order to facilitate quick and safe remittance of the valuable foreign exchanges earned by the expatriate Bangladeshi nationals. This has meant that the expatriates can remit their hard-earned money to the country with much ease, confidence, safety and speed
REGRESSION
In our report, we have been told to draw a Multiple linear regression between following variables where, The only dependent variable - Share price The 4 independent variables.1. Net income 2. Return on equity 3. Price earnings ratio 4. Dividend per share
Data Analysis:
Now we are prepared to use SPSS to compute all the statistics needed for the analysis. The Regression equation intercept is labeled as constant in the SPSS:
Model 1 (Constant)
Beta
Sig.
Bound
-.286 .786 -4035.664 .005 .019 .985 -.041 -.139 .895 .055 .278 .792 .963 4.335 .007
-179.343 160.883 .743 -.062 -.010 -124.542 154.709 .912 8.300 32.481 .986 .123 .020 .889 .312
In this case the estimated regression equation is =-404.174+3.834X1-9.230 X2+15.083 X3+20.391X4 Here, r =0.987 This is the multiple regressions and it indicates a positive relation between variables. It is close to 1 so we can say, there is strong positive relationship. Here, b1=3.834 it means that if the independent variable (Net income) increases by 1 taka then the dependent variable will increase by 3.834 taka. We can interpret other b by the same. We can now estimate the share price in next year as shown before. The regression coefficient and their algebraic signs, also provide information about their individual relationship with the next year share price. The regression coefficient for Net income is .005659. It is positive and shows a positive relationship between share price and net income. It is logical. Cause, net income and share price tend to move in same direction.
F 47.163
Sig. .000
a
Here, total variation is divided into 2 components: 1. variation in the dependent variable by the regression model( the independent variables) 2. The residual of error variation. That is the random error due to sampling. There are 3 categories identified in the 1st or source column in the Anova table: i. Regression ii. Residual iii.Total The 2nd column is labeled df in Anova table. It is the degree of freedom. Here total degrees of freedom are n-(k+1) = 10-(4+1) =5 The heading SS in the 3rd column of Anova table is the sum of squares or the variation. total variation= SStotal=1.367E8 Residual error= SSE= 3530134.188 Regression variation= 1.332E8 The 4th column heading MS or mean square. is obtained by dividing the SS quantity by the matching df. Thus the MSR , the mean square regression is equal to SSR/K. Similarly, MSE , the mean square error is SSE/ n-(k+1). (3530134.188/5)
Sig. level:0.05
4.76
Calculate value:47.163
COEFFICIENT OF DETERMINATION
r2= SSR total/SS total =.974 We interpret this value as, independent variables explain or account for, 97.4% of the variation in share price.
Model Summary
b
DurbinWatson 2.660
Square .974
COMPANY PROFILE
AB Bank Limited, the first private sector bank was incorporated in Bangladesh on 31st December 1981 as Arab Bangladesh Bank Limited and started its operation with effect from April 12, 1982. AB Bank is known as one of leading bank of the country since its commencement 29 years ago. It continues to remain updated with the latest products and services, considering consumer and client perspectives. AB Bank has thus been able to keep their consumers and clients trust while upholding their reliability, across time. In spite of adverse market conditions, AB Bank Limited which turned 28 this year, concluded the 2008 financial year with good results. The Banks consolidated profit after taxes amounted to Taka 230 cr which is 21% higher than that of 2007. The asset base of AB grew by 32% from 2007 to stand at over Tk 8,400 cr as at the end of 2008. AB Bank believes in modernization. The bank took a conscious decision to rejuvenate its past identity an identity that the bank carried as Arab Bangladesh Bank Limited for twenty five long years. As a result of this decision, the bank chose to rename itself as AB Bank Limited and the Bangladesh Bank put its affirmative stamp on November 14, 2007. AB Bank commits to nation to take a lead in the Banking sector through not only its strong financial position, but also through innovation of products and services. It also ensures creating higher value for its respected customers and shareholders. The bank has focused to bring services at the doorstep of its customers, and to bring millions into banking channels those who are outside the mainstream banking arena. Innovative products and services were introduced in the field of Small and Medium Enterprise (SME) credit, Womens Entrepreneur, Consumer Loans, Debit and Credit Cards (Local & International), ATMs, Internet and SMS Banking, Remittance Services, Treasury Products and Services, Structured Finance for Corporate, strengthening and expanding its Islamic Banking activities, Investment Banking, specialized products and services for NRBs, Priority Banking, and Customer Care. The Bank has successfully completed its automation project in mid 2008. It envisages enabling customers to get banking services within the comfort of their homes and offices. AB is recognized as the peoples choice, catering to the satisfaction of its cliental. Their satisfaction is ABs success.
AB BANK-DATA SUMMARY We collected 10 years data below from 2000 to 2009 of AB Bank Ltd. AB Bank Ltd.
YEAR 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 SHARE PRICE 109.02 213.35 254.58 211.66 257.25 315.14 566.91 1709.43 1934.14 831.85 NET PROFIT 158.86 263.28 23.69 17.12 90.07 162.45 532.19 1903.49 2300.62 3417.18 DPS 18.0 25.0 15.0 5.0 5.0 10.0 30.0 200.0 15.0 25.0 ROE 17.87 24.45 2.07 1.53 7.24 10.64 20.61 42.19 34.2 33.88 P/E 4.38 2.79 53.0 53.89 20.95 11.68 9.59 10.0 7.97 6.24 EPS 38.75 64.22 5.78 3.63 18.19 31.26 93.08 85.37 103.18 133.26
Data Analysis:
Descriptive Statistics Mean S.PRICE NP DPS ROE PE EPS 6.4033E2 8.8690E2 34.8000 19.4680 18.0490 57.6720 Std. Deviation 659.01034 1208.33008 58.65492 14.22683 19.29936 44.81578 N 10 10 10 10 10 10
Correlations S.PRICE Pearson Correlation S.PRICE NP DPS ROE PE EPS Sig. (1-tailed) S.PRICE NP DPS ROE PE EPS N S.PRICE NP DPS ROE PE EPS 1.000 .743 .582 .791 -.327 .657 . .007 .039 .003 .178 .020 10 10 10 10 10 10 NP .743 1.000 .345 .807 -.424 .868 .007 . .165 .002 .111 .001 10 10 10 10 10 10 DPS .582 .345 1.000 .633 -.224 .316 .039 .165 . .025 .267 .186 10 10 10 10 10 10 ROE .791 .807 .633 1.000 -.727 .885 .003 .002 .025 . .009 .000 10 10 10 10 10 10 PE -.327 -.424 -.224 -.727 1.000 -.695 .178 .111 .267 .009 . .013 10 10 10 10 10 10 EPS .657 .868 .316 .885 -.695 1.000 .020 .001 .186 .000 .013 . 10 10 10 10 10 10
Model Summary
DurbinWatson 1.616
Square .772
a. Predictors: (Constant), EPS, DPS, PE, NP, ROE b. Dependent Variable: S.PRICE
Our findings from regression analysis: R=.879; this suggests that there is very strong relationship among dependent variable that is share price and independent variables such as net income, DPS, EPS, ROE and P/E ratio.
R2=.772; this indicates 77.2% of dependent variables: share price can be explained by independent variables: net income, DPS, EPS, ROE, P/E ratio.
95% Confidence Interval for B Lower Upper Bound 3204.574 -.917 -17.960 -79.882 -31.918 -38.220 1725.574 1.058 .743 .099 .047 -.093 .313 .242 -.116 Correlations Zeroorder Partial Part
Model 1 (Constant)
B 739.500
Beta
Sig.
Bound
-.833 .452 .130 .199 .852 -.198 -.391 .715 1.544 1.312 .260 .536 1.012 .369 -.388 -.487 .652
.134 7.474 .224 4.473 .041 24.344 .203 4.932 .090 11.144
Regression equation Y = -739.50+ .071x1-2.219x2+71.526X3+18.319X4-5.70X5 Constant a= -739.50 indicates that share price is equal to -739.50 tk irrespective of the independent variables. b1=.071 suggests that for each million tk increase in net income share price is increased by tk .071 m. b2=-2.219 suggests that for each additional % increase in DPS share price is decreased by 2.219%. b3=71.526 suggests that for each percent increase in ROE share price is increased by 71.526%. b4=18.319 suggests that for each time increase in P/E ratio share price is increased by 18.319 times. b5=-5.70 suggests that for each additional % increase in EPS share price is decreased by 5.70%
1=.130, 2=-0.198, 3=1.544, 4=0.536 and 5=-.388 Beta measures strength of influence of the independent variable over the dependent variable. Among the Betas 3 is the highest so that we can say upon the share price influence ROE is the strongest.
ANOVA Model 1 Regression Residual Total Sum of Squares 3018517.397 890134.226 3908651.623 df
F 2.713
Sig. .178
a
a. Predictors: (Constant), EPS, DPS, PE, NP, ROE b. Dependent Variable: S.PRICE
With df=5 and df=4 table value of F=6.26 and calculated value of F=2.713 where F<F table value means all regression co-efficient are zero that is say for AB bank share price none of the independent variable have the ability to explain the variation in the dependent variable.
Fig:1
COMPANY PROFILE
The Company started its operations as Pfizer (Bangladesh) Limited in 1972. For the next two decades it continued as a highly successful subsidiary of Pfizer Corporation. However, by the late 1990s the focus of Pfizer had shifted from formulations to research. In accordance with this transformation, Pfizer divested its interests in many countries, including Bangladesh. Specifically, in 1993 Pfizer transferred the ownership of its Bangladesh operations to local shareholders, and the name of the company was changed to Renata Limited.
In a gesture of corporate charity, Pfizer donated shares so that, along with a partial payment from the SAJIDA Foundation, 51% ownership of Renata Limited would be held by the Foundation. Today SAJIDAs microfinance and micro-insurance programs support over 107,120 members and their families; thus far cumulative loan disbursement totals BDT 5,750 million. Currently, SAJIDAs health program covers over 1 million beneficiaries by delivering services through two 70 bed hospitals, panel doctors in SAJIDAs micro finance branches, and mobile health teams. To date, the SAJIDA Foundation holds the majority ownership in Renata Limited.
P/E
4.34 4.12 4.16 5.55 12.27 10.43 23.14 40.31 32.5 35.09
NP
35.56 67.23 72.56 105.56 145.59 192.57 242.13 358.02 438.67 590.48
Where market price is dependent variable and ROE, DPS, P/E, and NP are independent variable.
Data Analysis:
Model Summary
b
DurbinWatson 2.493
Square .980
INTERPRETATION
OF
THE
COEFFICIENT
OF
MULTIPLE
DETERMINATIONS (R2)
The model summary shows some important indicators of the explaining power of the model. The R-square value shows the percent of variation in the dependent variable is explained by the set of independent variables. In this case, r-square value of .980 or 98.0% means that the independent variables (return on equity, dividend per share, price earnings ratio, and net income) explain 98.0 percent of change in share price.
INTERPRETATION
OF
ADJUSTED
COEFFICIENT
OF
DETERMINATION (R2adj):
On the other hand, the adjusted r-square value shows the percent of variation in the dependent variable is explained by the statistically significant independent variables. So in this case, an adjusted r-square value of .964 or 96.4% means that the statistically significant independent variables explain 96.4 percent of the variation in labor productivity and it also indicates the model has the strong predictive power. If we compare R-square (.980) to the adjusted R-square (.964), the difference in this case is small.
F 60.819
Sig. .000
a
Now we are testing the ability of the independent variables X1, X2Xk to explain the behavior of the dependent variable y. this test is called global test. It mainly investigates whether it is possible all the independent variables have zero regression coefficients. We will test whether the independent variable (DPS, net income, P/E ratio) effectively estimates the market price of share. In testing hypothesis, we first state the null hypothesis and the alternate hypothesis. We have 4 independent variables such as b1, b2, b3, b4 are simple regression coefficients. The corresponding coefficients in the population are given in the symbol 1, 2, 3, 4. The null hypothesis is Ho: 1= 2= 3= 4 = 0 The alternate hypothesis is
H1: Not all the s are 0
If the null hypothesis is true, it implies the regression coefficients is 0 and logically are of no use in estimating the dependent variable. We have to search some for other independent variable to predict share price. To test null hypothesis that the multiple regression are all 0, we have to find out a critical value. From appendix B.4 in our test book and we have used 0.05 significant level. Here the degree of freedom in numerator is 4 because there are 4 independent variables and the degree of denominator is 5 founded by {n-(k+1)} =10-(4+1) =5. So the critical value is 5.41. The region where Ho is not rejected and the region where Ho is rejected are shown in the following diagram.
Continuing with the global test, the decision tool is not to reject the null hypothesis. The computed value of f is less than or equal 4.76. If the computed value is more than 4.76 then we reject the Ho.
SSR/k
F=
SSE/[m-(k+1)]
= 60.819 The computed value of F is 60.81 which is in the rejection region. The null hypothesis that the multiple regression coefficients are 0 is therefore rejected. This means that sum of the independent variables have the ability to explain the variation in the dependent variable.
For DPS
1 = 0 1 0
2 = 0 2 0
3 = 0 3 0
Collinearity Statistics
Model
Beta
Sig.
Bound
VIF
.678 -4178.892 2956.941 .702 .584 .428 .001 -379.175 -157.615 -159.778 14.340 521.003 99.219 79.503 33.743 .663 .688 .880 .988 .178 .026 .077 12.912 .075 13.349 .132 7.570 .122 8.211
-.136 -.151
1.158 6.370
The regression model is Y= -610.976 + 70.914X1 -29.198X2 -40.138 X3 +24.041 X4 The intercept value of -610.976 indicates the regression intersect the Y-axis at -610.976 when X1, X2, X3, and X4 are 0.
b1 of 70.914indicates that for each increase in 1% ROE, share price will increase by 70.914Tk. b2 of -29.198 indicates that for each increase in 1tk. DPS, share price will decrease by 29.198Tk. b3 of -40.138 indicates that for each increase in 1tk. Price Earnings ratio, share price will decrease by 40.138 Tk. b4 of 24.041 indicates that for each increase in 1 million tk., Net Profit share price will increase by 24.041Tk. As b1 is highest, it means that influence of Net Profit is fluctuating over increasing market share price.
The sample distribution of coefficient follows the t distribution n-(k+1). Hence we are able to test independent variables individually to determine whether the regression coefficients differ from 0. The computed t ratio is 0.405 for ROE, -.584 for DPS, 0.862 for P/E ratio and 4.335 for Net Profit. The regression coefficient for Net Profit is not 0 because it is right to the 2.571 and ROE, P/E ratio and DPS fall into the region within 6.370. So independent variable P/E ratio, DPS and ROE have no effect over dependent variable. It can be dropped from the analysis. So we can conclude that only Net Profit makes an impact over changing market share price.
COMPANY PROFILE
The company was incorporated in 1976 and commenced operations in 1980 with the manufacturing and marketing of products of Bayer AG, Germany and Upjohn Inc., USA under licensing arrangements. In 1983, the company started manufacturing its own formulations and it launched export operation in 1992. In 2005 Beximco Infusions Ltd, the company that produces intravenous fluids, was amalgamated with the parent company. In the same year it completed the state-of-the-art oral solid dosage plant in compliance with the US FDA and UK MHRA standards, which has been approved by major global regulatory bodies. Today Beximco Pharma is the largest exporter of pharmaceuticals in the country and the only company to win National Export Trophy (Gold), the highest national accolade for export, for record three times. The company is the largest producer of Metered Dose Inhalers (MDIs) in the country, and the first to produce CFC free inhalers. BPL is also the first company to produce anti-retroviral drugs (ARVs) locally. As a public limited company, its shares are actively traded in Dhaka Stock Exchange and Chittagong Stock Exchange, and Beximco Pharma has the unique distinction of being the only company in the country listed on AIM of London Stock Exchange. Beximco Pharmaceuticals Ltd (BPL) is a leading manufacturer of pharmaceutical formulations and Active Pharmaceutical Ingredients (APIs) in Bangladesh. The company is the largest exporter of pharmaceuticals in the country and its state-of-the-art manufacturing facilities are certified by global regulatory bodies of Australia, Gulf nations, Brazil, among others. The company is consistently building upon its portfolio and currently producing more than 400 products in different dosage forms covering broader therapeutic categories which include antibiotics, antihypertensives, antidiabetics, antireretrovirals, anti asthma inhalers etc, among many others.
Data Analysis:
Descriptive Statistics Mean S.PRICE NP DPS ROE PE EPS 68.6580 4.1614E2 19.0000 6.7520 18.6920 4.6420 Std. Deviation 36.68643 120.08351 6.14636 2.09492 13.25298 1.42170 N 10 10 10 10 10 10
Correlations S.PRICE Pearson Correlation S.PRICE NP DPS ROE PE EPS Sig. (1-tailed) S.PRICE NP DPS ROE PE EPS N S.PRICE NP DPS ROE PE EPS 1.000 .863 .050 -.221 .774 -.094 . .001 .446 .270 .004 .398 10 10 10 10 10 10 NP .863 1.000 -.075 .011 .593 .157 .001 . .419 .488 .035 .333 10 10 10 10 10 10 DPS .050 -.075 1.000 -.125 .486 -.133 .446 .419 . .366 .077 .357 10 10 10 10 10 10 ROE -.221 .011 -.125 1.000 -.516 .916 .270 .488 .366 . .063 .000 10 10 10 10 10 10 PE .774 .593 .486 -.516 1.000 -.494 .004 .035 .077 .063 . .073 10 10 10 10 10 10 EPS -.094 .157 -.133 .916 -.494 1.000 .398 .333 .357 .000 .073 . 10 10 10 10 10 10
Model Summary
DurbinWatson 1.678
Square .910
Our findings from regression analysis: R=.954; this suggests that there is very strong relationship among dependent variable that is share price and independent variables such as net income, DPS, EPS, ROE and P/E ratio. R2=.910; this indicates 91% of dependent variables: share price can be explained by independent variables: net income, DPS, EPS, ROE, P/E ratio.
Coefficients Unstandardized Coefficients Std. Model B Error 37.977 .134 1.779 Beta t Standardized Coefficients
95% Confidence Interval for B Lower Sig. Bound Upper Bound Correlations Zero-
Collinearity Statistics
VIF
.279 .794 -94.845 116.039 .024 .055 .959 -.461 1.546 .197 -.363 -7.687 .378 2.189 .863 .028 .008 .231 .132 .117 8.517 .253 3.960
.050 -.611
ROE
PE EPS
60.481 -.094
i.
Regression equation Y = 10.597+ .007x1-2.749x2-6.389X3+3.228X4+19.392X5 Constant a= 10.597indicates that share price is equal to 10.597 tk irrespective of the independent variables. b1=.007 suggests that for each million tk increase in net income share price is increased by tk .007 m. b2=-2.749 suggests that for each additional % increase in DPS share price is decreased by 2.749%. b3=-6.389 suggests that for each % increase in ROE share price is decreased by 6.389%. b4=3.228 suggests that for each time increase in P/E ratio share price is increased by 3.228 times. b5=19.392 suggests that for each additional % increase in EPS share price is increased by 19.392%
1=.024, 2=-0.461, 3=-.365, 4=1.166 and 5=.756 Beta measures strength of influence of the independent variable over the dependent variable. Among the Betas 4 is the highest so that we can say upon the share price influence of P/E ratio is the strongest.
ANOVA Model 1 Regression Residual Total Sum of Squares 11026.735 1086.315 12113.051 df
F 8.120
Sig. .032
a
With df=5 and df=4 table value of F=6.26 and calculated value of F=8.120 where F>F table value means all regression co-efficient are not zero that is to say for Beximo Pharmaceuticals share price some of the independent variable do have the ability to explain the variation in the dependent variable.
CONCLUSION
The aim of the report was to establish and define the association between the share prices of a company and the performance indicators. Throughout the analysis of the report it was possible to successfully establish such a relation between them and to define them to significant precision. Although the analysis is based on only the past records it, nevertheless, would help us to predict the future trend of share prices in response to the performance indicators of the particular companies. The analysis is also a helpful in understanding of the effectiveness of the company performance on its share prices. It not only relates to the only four companies we have dealt with, but the overall capital market.
BIBLIOGRAPHY
1. Text Books
i) ii) Statistical Techniques in Business & Economics by Douglas A. Lind, William G. Marchal, Samuel A. Wathen. Principles of Statistics
2. Websites
i) ii) iii) iv) National Bank Ltd (www.nblbd.com) AB Bank Ltd. (www.abbank.com.bd) Renata Pharmaceuticals (www.renata.com) Beximco Pharmaceuticals Ltd. (www.beximco.com)